Yervoy setback in prostate cancer
September 16, 2013Research and Development, Sales and Marketing BMS, Yervoy, melanoma, prostate cancer
Bayer faces China investigation
September 16, 2013Medical Communications, Sales and Marketing Bayer, China, corruption
Now China’s pharma firms under spotlight
September 13, 2013Medical Communications, Sales and Marketing Chia Tai Tianqing Pharmaceutical, China, bribery, corruption, pharma
The net cast out by Chinese authorities over the country’s pharma industry may be about to ensnare its first domestic …
Fake drugs warning from pharma
September 13, 2013Manufacturing and Production, Sales and Marketing EFPIA, WHO, counterfeit, viagra
Pharma has warned that not enough is being done to protect consumers from counterfeit medicines – particularly those bought online …
Quintiles president to chair Idis
September 13, 2013Manufacturing and Production, Research and Development, Sales and Marketing IDIS, Quintiles, thomis
Former Quintiles president Jeff Thomis has been appointed to the role of chairman at Idis. In his new role, Thomis …
Bayer partners with US academics
September 13, 2013Research and Development, Sales and Marketing Bayer, Cancer, broad, oncology
Bayer HealthCare and a prestigious US academic institution have signed a five-year deal to find new oncology treatments. The German …
Hunt: GPs to care for elderly
September 12, 2013Sales and Marketing GP, Hunt, NHS, elderly
Health secretary Jeremy Hunt says that GPs are in line to become the named clinician responsible for elderly people’s care …
Sanofi withdraws lixisenatide US application
September 12, 2013Sales and Marketing FDA, Lixisenatide, Sanofi, diabetes, elixa
In a blow to its diabetes pipeline, Sanofi has withdrawn a new drug application (NDA) for lixisenatide in the US …
Amicus links with Biogen Idec
September 12, 2013Research and Development, Sales and Marketing Amicus, Biogen IDEC, Parkinson's
Amicus Therapeutics and Biogen Idec have signed a collaboration agreement which will see them look for novel small molecules for …
LipoScience reappoints chief medical officer
September 12, 2013Manufacturing and Production, Research and Development, Sales and Marketing cromwell, liposcience
Diagnostics firm LipoScience has once again hired William Cromwell to be its chief medical officer. He joins the company for …
UK trial rules tightened up
September 11, 2013Research and Development, Sales and Marketing all trials, hra, transparency
Anyone wanting to conduct clinical trials in the UK will have to register their research in order to receive a …
AstraZeneca pays Merck for cancer drug
September 11, 2013Sales and Marketing AstraZeneca, Cancer, Merck, WEE1
AstraZeneca is to pay $50 million up front to get a worldwide licensing deal for one of Merck’s investigational drugs …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
